Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

From a purple dot in Wuhan, China, lines start to emerge, reaching the UK, Thailand, and Australia. New colors appear, representing genetic changes that occur in the SARS-CoV-2 coronavirus as it moves, infects large groups of people, and mu

NEW YORK LexaGene, which has developed a pathogen detection platform for the veterinary and food safety sectors, is now pivoting to clinical diagnostics by modifying its LX Analyzer platform for viruses, including SARS-CoV-2, the virus behi

NEW YORK A team led by researchers at St. Jude Childrens Research Hospital, the European Molecular Biology Laboratory, and the German Cancer Research Center have identified a novel inherited gene that predisposes children to developing the

Nefertiti Brown, MDs life is on pause right now. The 39-year-old physician is quarantined in her home, awaiting results from a COVID-19 test she took nearly two weeks ago. Dr. Brown, a graduate of the University of Pittsburgh School of Medi

Abbotts new ID NOW COVID-19 test, which earned emergency use authorization (EUA) from FDA last week, was highlighted during President Donald Trumps COVID-19 taskforce press briefing on March 30. FDA Commissioner Stephen Hahn spoke about the

A smallSan Diego, CA-based company has joined the ongoing battle against the new coronavirus. Cue Medical secured a U.S. government contract to deliver itsportablepoint-of-care diagnostic test for the detection of SARS-Cov-2, the virus that

Grail has some solid results coming from its multi-cancer early detection blood test. The liquid biopsy specialist revealed data that shows its technology can detect more than 50 cancer types across all stages, with a very low false-positiv

Siemens Healthineers is adding more firepower in the fight to make more novel coronavirus (SARS-CoV-2) diagnostics available. The company said its Fast Track Diagnostics (FTD) SARS-COV-2 Assay is already being shipped in Europe for research

The Austin TX-based company was granted Emergency Use Authorization for the Aries SARS-CoV-2 Assay and the NxTAG CoV Extended Panel to help in the detection of the novel coronavirus.

NEW YORK Bio-Rad Laboratories has developed an assay to detect the SARS-CoV-2 virus, cause of the COVID-19 pandemic, using its droplet digital PCR systems, and similar ddPCR tests have been shown in recent preliminary studies to reduce fals